Ticker

Siemens Healthineers AG (SMMNY) Discusses Q3 Pre-Close Updates: Foreign Exchange and Tariff Impacts on Revenue and Earnings Prepared Remarks Transcript

Worcester, MA, May 26, 2026 (GLOBE NEWSWIRE) -- AiM Medical Robotics, a leading developer of advanced robotic systems for MRI-guided neurosurgery, today announced a collaboration agreement with Siemens Healthineers for the implementation of an interface enabling AiM's robotic platform to operate with MRI systems from Siemens Healthineers. The interface supports the integration of AiM's compact, MRI-compatible…

Siemens Healthineers is rated a 'BUY' with a lowered price target of €48/share and a fair value of €58/share, reflecting recent strategic changes. Recurring revenue, market leadership in imaging and therapies, and robust CapEx underpin SHL's financial stability and long-term appeal despite macro headwinds. The diagnostics carve-out and Siemens AG's share divestment introduce risks, reduce business integration, and…

Siemens Healthineers on Thursday cut ​its full year outlook ‌to forecast revenue growth of between ​4.5% and 5.0% ​for the 2026 financial ⁠year due to ​weakness in China's ​diagnostics market and higher inflation during the quarter.

Razor and blades model of equipment and then servicing in the healthcare space piques interest here. Free cash flow yields aren't bad for a company with medical end markets and some leading franchises, particularly Varian. While dis-synergies are coming, the model compounds nicely as the base grows, and Varian's leadership in the mix should lift margins and its own economics with scale.